Buy Cascadian Therapeutics Stock | CASC Stock Price & Latest News | Public
CASC

Cascadian Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About CASC

    Cascadian Therapeutics, a clinical-stage biopharmaceutical company, researches and develops, and sells therapeutic products for the treatment of cancer in the United States. The company lead clinical-stage product candidate is tucatinib, an orally active and HER2-selec...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High
    1 Year Low
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app